Reporting to the CEO (and eventually to the Chief Commercial Officer), the Vice President of Marketing will be responsible for the development of the global marketing strategy, and the planning and execution of tactics to optimize the adoption and use of XPOVIO. The near-term focus is on maximizing the July 2019 launch of XPOVIO plus dexamethasone as the standard of care for patients with relapsed or refractory multiple myeloma who had received proteasome inhibitors, IMiDs and anti-CD38 Mab therapy and planning for the 2020 launches of indications in earlier lines of treatment in multiple myeloma and in DLBCL. The VP will also be responsible for developing the marketing strategy for additional indications in hematological malignancies and solid tumors.
The VP will manage groups responsible for product management, marketing operations, market research and competitive intelligence. This leadership role is responsible for: marketing to all external customers, leading agency and vendor relationships, establishing KOL relationships and leading cross functional collaboration internally and externally. The VP will work closely with a breadth of Karyopharm functional groups, including but not limited to Sales, Market Access, Regulatory Affairs, Legal, Medical Affairs, as well as business partners to ensure organizational alignment with the commercialization strategy of Selinexor.
In this leadership position, this executive will help establish commercial and corporate goals, and to advocate for the required budget and resources from the executive team and board of directors.
Karyopharm Therapeutics is a fully integrated pharmaceutical company focused on the discovery, development and commercialization of novel first in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases.
Karyopharm Therapeutics Inc. (the "Company") is an equal opportunity employer. All qualified applicants will be considered without regard to age, race, color, sex, religion/creed, national origin, marital status, ancestry, citizenship, military, reservist or veteran status, pregnancy, sexual orientation or preference, gender identity, gender expression, physical or mental disability, genetic predisposition or carrier status, or any other category protected under applicable federal, state or local law. Consistent with its obligations under applicable law, the Company will make reasonable accommodations for qualified individuals with disabilities. If you require an accommodation in the application process, please contact a member of the Company’s Human Resources department.